These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30299271)

  • 21. Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Kuno T; Ueyama H; Takagi H; Ando T; Numasawa Y; Briasoulis A; Fox J; Bangalore S
    Am J Cardiol; 2020 Feb; 125(4):521-527. PubMed ID: 31839147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
    Gibson CM; Mehran R; Bode C; Halperin J; Verheugt F; Wildgoose P; van Eickels M; Lip GY; Cohen M; Husted S; Peterson E; Fox K
    Am Heart J; 2015 Apr; 169(4):472-8.e5. PubMed ID: 25819853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study.
    Russo V; Rago A; Proietti R; Attena E; Rainone C; Crisci M; Papa AA; Calabrò P; D'Onofrio A; Golino P; Nigro G
    Biomed Res Int; 2019; 2019():5473240. PubMed ID: 30895193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant Use of Antiplatelets and Anticoagulants in Patients with Coronary Heart Disease and Atrial Fibrillation: What Do Recent Clinical Trials Teach Us?
    Lam DH; Bell SM; Hira RS
    Curr Atheroscler Rep; 2018 Jan; 20(1):4. PubMed ID: 29349596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
    Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
    J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
    Saglietto A; D'Ascenzo F; Errigo D; Leonardi S; Dewilde WJ; Conrotto F; Omedè P; Montefusco A; Angelini F; De Filippo O; Bianco M; Gallone G; Bruno F; Zaccaro L; Giannini F; Latib A; Colombo A; Costa F; De Ferrari GM
    Catheter Cardiovasc Interv; 2021 Mar; 97(4):581-588. PubMed ID: 32790145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction.
    Madsen JM; Jacobsen MR; Sabbah M; Topal DG; Jabbari R; Glinge C; Køber L; Torp-Pedersen C; Pedersen F; Sørensen R; Holmvang L; Engstrøm T; Lønborg JT
    Am Heart J; 2021 Aug; 238():89-99. PubMed ID: 33957102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Fanaroff AC; Lopes RD
    Prog Cardiovasc Dis; 2021; 69():11-17. PubMed ID: 34883097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.
    Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Vranckx P; Goette A; Gibson CM; Alexander JH
    JAMA Cardiol; 2020 May; 5(5):582-589. PubMed ID: 32101251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Sindet-Pedersen C; Staerk L; Lamberts M; Gerds TA; Berger JS; Nissen Bonde A; Langtved Pallisgaard J; Hansen ML; Torp-Pedersen C; Gislason GH; Bjerring Olesen J
    Heart; 2018 Jun; 104(11):912-920. PubMed ID: 29092916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction.
    Zhang Z; Si D; Zhang Q; Qu M; Yu M; Jiang Z; Li D; Yang P; Zhang W
    Heart Vessels; 2022 Mar; 37(3):374-384. PubMed ID: 34420077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison Between Long-Term Clinical Outcomes of Vitamin K Antagonist and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Yoshida R; Morishima I; Takagi K; Morita Y; Tsuboi H; Murohara T
    Circ J; 2018 Jul; 82(8):2016-2024. PubMed ID: 29863094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction.
    Lee SJ; Cho JY; Kim BK; Yun KH; Suh Y; Cho YH; Kim YH; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon HM; Hong SJ; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y;
    JACC Cardiovasc Interv; 2021 Feb; 14(4):431-440. PubMed ID: 33602439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial.
    Zeymer U; Leiva O; Hohnloser SH; Steg PG; Oldgren J; Nickenig G; Gabor Kiss R; Ongen Z; Navarro Estrada J; Oude Ophuis T; Lip GYH; Nordaby M; Miede C; Ten Berg JM; Bhatt DL; Cannon CP
    EuroIntervention; 2021 Aug; 17(6):474-480. PubMed ID: 33164896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation.
    Jensen T; Thrane PG; Olesen KKW; Würtz M; Mortensen MB; Gyldenkerne C; Thim T; Nørgaard BL; Jensen JM; Kristensen SD; Nielsen JC; Eikelboom JW; Maeng M
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):208-219. PubMed ID: 36269306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.
    Eyileten C; Postula M; Jakubik D; Toma A; Mirowska-Guzel D; Patti G; Renda G; Siller-Matula JM
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.